Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.06. | Petros Pharmaceuticals will Tochtergesellschaft ausgliedern, um Finanzen zu verbessern | 11 | Investing.com Deutsch | ||
25.06. | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position | 339 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the... ► Artikel lesen | |
20.06. | Petros Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
21.05. | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets | 305 | ACCESS Newswire | The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on... ► Artikel lesen | |
21.05. | Petros Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
PETROS PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
20.05. | Petros Pharmaceuticals partners with Innolitics for SaaS platform | 7 | Investing.com | ||
20.05. | Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development | 3 | Seeking Alpha | ||
20.05. | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer | 553 | ACCESS Newswire | With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform. NEW YORK, NY / ACCESS Newswire / May 20, 2025... ► Artikel lesen | |
15.05. | Petros Pharmaceuticals, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
06.05. | Petros Pharmaceuticals verbessert KI für Rx-to-OTC-Wechselplattform | 13 | Investing.com Deutsch | ||
06.05. | Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform | 2 | Investing.com | ||
06.05. | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform | 293 | ACCESS Newswire | Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petros... ► Artikel lesen | |
02.05. | Petros Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
01.05. | Petros Pharmaceuticals schwenkt auf intelligente Gesundheitstechnologie um | 5 | Investing.com Deutsch | ||
01.05. | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches | 378 | ACCESS Newswire | Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again... ► Artikel lesen | |
29.04. | Petros Pharmaceuticals gears up for Rx-to-OTC switch platform | 7 | Investing.com | ||
29.04. | Petros Pharmaceuticals, Inc.: Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms | 428 | ACCESS Newswire | Company's AI and Big Data technology positioned to drive strong industry collaborationCompany also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmaceuticals... ► Artikel lesen | |
09.04. | Petros Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.03. | Petros Pharmaceuticals enhances Rx-to-OTC switch technology | 7 | Investing.com | ||
20.03. | Petros Pharmaceuticals verbessert Rx-to-OTC-Umstellungstechnologie | 4 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 28,060 | +0,48 % | Massive UNTERBEWERTUNG?! Bayer, SFC Energy, Veganz Group Aktie | Massive Unterbewertung bei der Veganz-Aktie? Die Transformation vom Anbieter veganer Lebensmittel zum Food-Tech-Unternehmen nimmt immer mehr Form. Die erste Lieferung der in einem revolutionären Verfahren... ► Artikel lesen | |
GILEAD SCIENCES | 96,04 | -0,57 % | EU Approves Gilead's Twice-Yearly Lenacapavir For HIV Prevention | FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) Tuesday said that the European Commission has granted marketing authorization for lenacapavir for pre-exposure prophylaxis to reduce the... ► Artikel lesen | |
AURORA CANNABIS | 4,600 | 0,00 % | Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting | NASDAQ | TSX: ACB
EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada -based... ► Artikel lesen | |
ABBVIE | 179,60 | -0,22 % | AbbVie's RINVOQ Secures Health Canada's Approval For Giant Cell Arteritis Treatment | WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV), Wednesday announced Health Canada has issued a Notice of Compliance for RINVOQ for the treatment of adults with giant cell arteritis, both used in... ► Artikel lesen | |
CANOPY GROWTH | 1,520 | -0,39 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Apple, Canopy Growth & Alcon) | ||
ELI LILLY | 625,90 | -0,03 % | Novo Nordisk: Aktie wieder auf dem absteigenden Ast - Eli Lilly legt nach | Das Rennen um die beste Abnehmpille ist längst eröffnet. Und einmal mehr bietet sich das Top-Duo im aufstrebenden Adipositas-Markt die Stirn: Eli Lilly und Novo Nordisk. Während die Dänen ihre Abnehmspritze... ► Artikel lesen | |
ASTRAZENECA | 136,30 | -0,44 % | DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11000 Pence auf "Hold" belassen. Dies schrieb Analyst Emmanuel Papadakis in seiner am... ► Artikel lesen | |
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 1,181 | -0,51 % | Kursziel 2 US-Dollar: Trumps Cannabis-Kurswechsel: Tilray-Aktie im Kursrausch | © Foto: Bebeto Matthews - APDie Cannabis-Branche in den USA steht vor einem möglichen Richtungswechsel - und Tilray könnte der große Profiteur sein. Das Analysehaus Jefferies hebt sein Kursziel an,... ► Artikel lesen | |
BRISTOL-MYERS SQUIBB | 40,245 | -0,26 % | Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025 | Findings from COLLIGO-HCM reinforce Camzyos' efficacy and safety profile in reducing left ventricular outflow tract (LVOT) obstruction and improving symptom burden in a racially diverse, global... ► Artikel lesen | |
TEVA | 15,800 | +0,32 % | Neues Abnehmmittel kommt!: Vorsicht Novo Nordisk & Eli Lilly - Teva bringt "Abnehm-Generika" auf US-Markt! | Novo Nordisk und Eli Lilly bekommen Konkurrenz: Teva steigt mit einem Generikum in den US-Markt für Abnehmpräparate ein. Mit der FDA-Zulassung steigt der israelische Pharmariese in den milliardenschweren... ► Artikel lesen | |
INNOCAN PHARMA | 0,131 | +3,56 % | "Poster"-News: Innocan Pharma - Durchbruch auf der PAINWEEK! | ||
ABBOTT LABORATORIES | 113,22 | -0,19 % | Abbott Gets CE Mark For Expanded Indication For Navitor TAVI System | NORTH CHICAGO (dpa-AFX) - Abbott (ABT) has received CE Mark in Europe for an expanded indication for the Navitor transcatheter aortic valve implantation system to treat people with symptomatic... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
DERMAPHARM | 32,900 | -0,30 % | Ihre wichtigsten Termine: Neue Zahlen-Updates von: Dermapharm, Baywa, SFC Energy, DZ Bank und Dekabank | © Foto: Christian Charisius - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen |